zalcitabine has been researched along with Cytomegalovirus Retinitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranowski, E; Kaulen, P; Pham, DT; Wollensak, J | 1 |
| AbdelHameed, MH; Dorr, A; Griffy, K; Jung, D; Teitelbaum, P | 1 |
| Mascolini, M | 1 |
2 trial(s) available for zalcitabine and Cytomegalovirus Retinitis
| Article | Year |
|---|---|
Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4-CD8 Ratio; Cytomegalovirus Retinitis; Drug Therapy, Combination; HIV Infections; Humans; Incidence; Male; Prospective Studies; Zalcitabine; Zidovudine | 1993 |
The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients.
Topics: Administration, Oral; Anti-HIV Agents; Antiviral Agents; Area Under Curve; Cross-Over Studies; Cytomegalovirus Retinitis; Drug Interactions; Female; Ganciclovir; HIV Seropositivity; Humans; Male; Stavudine; Zalcitabine | 1999 |
1 other study(ies) available for zalcitabine and Cytomegalovirus Retinitis
| Article | Year |
|---|---|
Clinical progress and transmission perils stressed at second human retroviruses conference.
Topics: Acyclovir; AIDS Vaccines; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Herpesviridae; HIV Infections; Humans; Interleukin-2; Lamivudine; Lymphoma, Non-Hodgkin; Retroviridae; Sarcoma, Kaposi; Zalcitabine; Zidovudine | 1995 |